Evidence map›Paper›PMID 34068184›Full record

ReviewMarine drugs2021

Marine Anthraquinones: Pharmacological and Toxicological Issues.

Giulia Greco, Eleonora Turrini, Elena Catanzaro, Carmela Fimognari

Abstract readReview
In one paragraph

Review in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. A perspective review on factors that influence mutagenicity in medicinal plants and their health implications.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giulia GrecoDepartment for Life Quality Studies, Alma Mater Studiorum, Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0000-0001-8174-9977
Eleonora TurriniDepartment for Life Quality Studies, Alma Mater Studiorum, Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0000-0003-4743-1126
Elena CatanzaroDepartment for Life Quality Studies, Alma Mater Studiorum, Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0000-0001-7699-3414
Carmela FimognariDepartment for Life Quality Studies, Alma Mater Studiorum, Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.ORCID 0000-0002-2461-8214

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The marine ecosystem, populated by a myriad of animals, plants, and microorganisms, is an inexhaustible reservoir of pharmacologically active molecules. Among the multiple secondary metabolites produced by marine sources, there are anthraquinones and their derivatives. Besides being mainly known to be produced by terrestrial species, even marine organisms and the uncountable kingdom of marine microorganisms biosynthesize anthraquinones. Anthraquinones possess many different biological activities, including a remarkable antitumor activity. However, due to their peculiar chemical structures, anthraquinones are often associated with toxicological issues, even relevant, such as genotoxicity and mutagenicity. The aim of this review is to critically describe the anticancer potential of anthraquinones derived from marine sources and their genotoxic and mutagenic potential. Marine-derived anthraquinones show a promising anticancer potential, although clinical studies are missing. Additionally, an in-depth investigation of their toxicological profile is needed before advocating anthraquinones as a therapeutic armamentarium in the oncological area.

Indexed as

AnimalsAnthraquinonesAntineoplastic AgentsAquatic OrganismsCell Line, TumorHumansMutagensNeoplasmsAnthraquinonesAntineoplastic AgentsMutagensanthraquinonesanticancer mechanismscytotoxicityfungigenotoxicityin vitro studiesin vivo studiesmarine organisms

Identifiers

PMID34068184
PMCPMC8152984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.